Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Vertex Pharmaceuticals Inc (NASDAQ:VRTX)

86.61
Delayed Data
As of Feb 05
 -5.11 / -5.57%
Today’s Change
81.98
Today|||52-Week Range
143.45
-31.17%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2015
Quarter 2
2015
Quarter 3
2015
Quarter 4
2015
Revenue and IncomeNet Revenues138.5M166.1M309.8M417.9M
 
 
 
 
 
Cost of Goods Sold4.1M2.8M15.8M64.4M
 
 
 
 
 
Depreciation And Amortization16.4M14.1M16.2M--
 
 
 
 
 
Operating ExpensesGross Income118.0M149.2M277.9M353.5M
 
 
 
 
 
General Expenses293.3M318.3M346.1M407.5M
 
 
 
 
 
Research And Development215.6M223.9M246.3M310.4M
 
 
 
 
 
Total Operating Expenses313.8M335.1M378.0M471.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-175.3M-169.0M-68.2M-54.0M
 
 
 
 
 
Extraordinary Credit3.3M--0.00--
 
 
Extraordinary Charge0.00-2.1M-1.8M-1.5M
 
 
 
 
Interest Expense On Debt21.3M21.1M21.1M20.7M
 
 
 
 
 
Other Expenses-5.1M1.4M-1.3M-1.7M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-198.4M-190.9M-92.5M-77.8M
 
 
 
 
 
Income Taxes-299.0K-30.1M-1.3M-1.4M
 
 
 
 
 
Minority Interest-98.0K-32.1M-1.3M-938.0K
 
 
 
 
 
Net Income-198.6M-188.8M-95.1M-75.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS239.5M240.8M242.0M243.0M
 
 
 
 
 
Shares To Calculate EPS Diluted239.5M240.8M242.0M243.0M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.83-$0.78-$0.39-$0.31
 
 
 
 
 
EPS Diluted-$0.83-$0.78-$0.39-$0.31